PL2470213T3 - Kompozycje do leczenia chorób lub zaburzeń neurodegeneracyjnych, sposób i zastosowanie obejmujące elektromagnetycznie napromienione drożdże - Google Patents

Kompozycje do leczenia chorób lub zaburzeń neurodegeneracyjnych, sposób i zastosowanie obejmujące elektromagnetycznie napromienione drożdże

Info

Publication number
PL2470213T3
PL2470213T3 PL10749635T PL10749635T PL2470213T3 PL 2470213 T3 PL2470213 T3 PL 2470213T3 PL 10749635 T PL10749635 T PL 10749635T PL 10749635 T PL10749635 T PL 10749635T PL 2470213 T3 PL2470213 T3 PL 2470213T3
Authority
PL
Poland
Prior art keywords
disorders
treatment
composition
neurodegenerative diseases
electromagnetically irradiated
Prior art date
Application number
PL10749635T
Other languages
English (en)
Inventor
Kent Törnqvist
Maria Sibileva
Peter Ek
Anders Fredriksson
Trevor Archer
Tatiana Blomqvist
Dmitry Mudrik
Natalia Golant
Ludmila Balakireva
Original Assignee
Milmed Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Milmed Ab filed Critical Milmed Ab
Publication of PL2470213T3 publication Critical patent/PL2470213T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Emergency Medicine (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL10749635T 2009-08-26 2010-08-26 Kompozycje do leczenia chorób lub zaburzeń neurodegeneracyjnych, sposób i zastosowanie obejmujące elektromagnetycznie napromienione drożdże PL2470213T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0950613 2009-08-26
PCT/EP2010/062490 WO2011023769A1 (en) 2009-08-26 2010-08-26 Composition for treatment of neurodegenerative diseases or disorders, method and use comprising electromagnetically irradiated yeast
EP10749635.8A EP2470213B1 (en) 2009-08-26 2010-08-26 Composition for treatment of neurodegenerative diseases or disorders, method and use comprising electromagnetically irradiated yeast

Publications (1)

Publication Number Publication Date
PL2470213T3 true PL2470213T3 (pl) 2014-05-30

Family

ID=43243750

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10749635T PL2470213T3 (pl) 2009-08-26 2010-08-26 Kompozycje do leczenia chorób lub zaburzeń neurodegeneracyjnych, sposób i zastosowanie obejmujące elektromagnetycznie napromienione drożdże

Country Status (10)

Country Link
US (2) US9320768B2 (pl)
EP (1) EP2470213B1 (pl)
JP (2) JP5905823B2 (pl)
CN (1) CN102481368B (pl)
DK (1) DK2470213T3 (pl)
ES (1) ES2441974T3 (pl)
PL (1) PL2470213T3 (pl)
PT (1) PT2470213E (pl)
SI (1) SI2470213T1 (pl)
WO (1) WO2011023769A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10398729B2 (en) * 2012-02-14 2019-09-03 Kenneth O. Russell Method for treating Alzheimer's disease
WO2011023769A1 (en) * 2009-08-26 2011-03-03 Mb Milmed Ab Composition for treatment of neurodegenerative diseases or disorders, method and use comprising electromagnetically irradiated yeast
WO2018022431A1 (en) * 2016-07-25 2018-02-01 Patch Sarah Kathryn Systems and methods for radiation beam range verification using sonic measurements
SE1951142A1 (en) * 2019-10-07 2020-11-24 Milmed Unico Ab Yeast for the treatment of allergy
WO2025262092A1 (en) * 2024-06-17 2025-12-26 Uni Europe 1 Ab Yeast for promoting longevity and/or anti-ageing

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1564189A1 (ru) * 1988-07-05 1990-05-15 Киевский Технологический Институт Пищевой Промышленности Способ выращивани дрожжей
WO2002062983A1 (fr) 2001-02-08 2002-08-15 Six Forest Bio-Science Institute Limited Levure faisant preuve d'une activite immunoregulatrice des lymphocytes t, son procede de preparation et ses applications
WO2002062982A1 (fr) * 2001-02-08 2002-08-15 Six Forest Bio-Science Institute Limited Levure faisant preuve d'une activite immunoregulatrice des lymphocytes b, son procede de preparation et ses applications
WO2002062984A1 (en) * 2001-02-08 2002-08-15 Six Forest Bio-Science Institute Limited The yeast with immunoregulation activity to the k cell as well as the production method and the use thereof
US20040005336A1 (en) * 2002-06-28 2004-01-08 Cheung Ling Yuk Dietary supplements for regulating the central nervous system
US20040001859A1 (en) 2002-06-28 2004-01-01 Cheung Ling Yuk Anti-aging dietary supplements
EA004756B1 (ru) 2002-10-25 2004-08-26 Сергей Дмитриевич Огурцов Способ воздействия на биологический объект и устройство для осуществления этого способа
TWI319708B (en) * 2005-10-14 2010-01-21 Methods and compositions for altering cell fuction
WO2011023769A1 (en) * 2009-08-26 2011-03-03 Mb Milmed Ab Composition for treatment of neurodegenerative diseases or disorders, method and use comprising electromagnetically irradiated yeast

Also Published As

Publication number Publication date
JP2013503138A (ja) 2013-01-31
SI2470213T1 (sl) 2014-04-30
JP5905823B2 (ja) 2016-04-20
US20160220621A1 (en) 2016-08-04
CN102481368B (zh) 2014-01-29
EP2470213A1 (en) 2012-07-04
US9320768B2 (en) 2016-04-26
PT2470213E (pt) 2014-01-20
US20120190095A1 (en) 2012-07-26
CN102481368A (zh) 2012-05-30
JP6139650B2 (ja) 2017-05-31
EP2470213B1 (en) 2013-10-16
JP2016094460A (ja) 2016-05-26
ES2441974T3 (es) 2014-02-07
DK2470213T3 (da) 2014-01-20
WO2011023769A1 (en) 2011-03-03

Similar Documents

Publication Publication Date Title
EP2467116A4 (en) METHOD AND APPARATUS FOR NON-INVASIVE AESTHETIC TREATMENT OF SKIN AND HYPODERM
EP2621420A4 (en) CORNEAL TREATMENT SYSTEM AND METHOD
IL212404A0 (en) Compounds for treating ophthalmic diseases and disorders
PL2512470T3 (pl) Oszczędzające ppar tiazolidynodiony i połączenia do leczenia chorób neurodegeneracyjnych
IL216967A0 (en) 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseases
IL207687A0 (en) Method of treating ocular diseases by gene therapy
EP2558104A4 (en) METHOD AND OPHTHALMIC COMPOSITION FOR TREATING RETINAL DISEASE
EP2401561A4 (en) DEVICE AND METHOD FOR TREATMENT BY CRYOTHERAPY
GB0915259D0 (en) Sulphur-linked compounds for treating ophthalmic diseases and disorders
ZA201203281B (en) Pharmaceutical combinations, pharmaceutical compositions, medicament and method for the treatment of animals
IL216951A0 (en) Method for treatment of diseases
ZA201109449B (en) Methods and products for treatment of diseases
SG10201405392RA (en) Method of treatment of neurodegenerative or neuro-muscular degenerative diseases andtherapeutic agent to treat the same
EP2709632A4 (en) COMPOSITIONS AND METHOD FOR THE TREATMENT OF SKIN DISEASES
PT2470213E (pt) Composição para tratamento de distúrbios ou doenças neurodegenerativas e método e utilização compreendendo levedura eletromageticamente irradiada
EP2502989A4 (en) IMPLANT COMPOSITION FOR THE REGENERATION OF NEURAL TISSUE, PREPARATION METHOD AND USES THEREOF
WO2011062762A3 (en) Angiogenin and variants thereof for treatment of neurodegenerative diseases
AP2011006014A0 (en) Method and device for treatment of human excrement.
EP2462131A4 (en) COMPOSITIONS AND METHODS FOR TREATING DISEASES ASSOCIATED WITH BETA-AMYLOID
IL213399A0 (en) Method of treatment of diseases using hoodia extracts
HK1168780A (en) Methods for treating or preventing ophthalmological diseases
GB0803515D0 (en) Medicament and method of treatment
HK1131749A (en) Cancer treatment medicament, use and method of manufacture thereof
HK1168249A (en) Methods and products for treatment of diseases
AU2009904136A0 (en) Method for treatment and diagnosis